Biomedical Engineering Reference
In-Depth Information
Cutrin JC, Crich SG, Burghelea D, Dastru W, Aime S (2013) Curcumin/Gd loaded apoferritin: a
novel “theranostic” agent to prevent hepatocellular damage in toxic induced acute hepatitis.
Mol Pharm 10:2079-2085
Das S, Chaudhury A (2011) Recent advances in lipid nanoparticle formulations with solid matrix
for oral drug delivery. AAPS Pharm Sci Tech 12:62-76
Das T, Chakraborty S, Sarma HD, Banerjee S, Venakatesh M (2010) A novel 177Lu-labeled por-
phyrin for possible use in targeted tumor therapy. Nucl Med Biol 37:655-663
Davis ME, Zuckerman JE, Choi CHJ, Seligson D, Tolcher A, Alabi CA, Yen Y, Heidel JD, Ribas
A (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted
nanoparticles. Nature 464:1067-1070
Deepagan VG, Sarmento B, Menon D, Nascimento A, Jayasree A, Sreeranganathan M,
Koyakutty M, Nair SV, Rangasamy J (2012) In vitro targeted imaging and delivery of camp-
tothecin using cetuximab-conjugated multifunctional PLGAZnS nanoparticles. Nanomed
(Lond) 7(4):507-519
Delgadoa D, Gascóna AR, Rodrígueza AP, Echevarríab E, Garibaya APR, Rodríguezb JM,
Solinís MÁ (2012) Dextran-protamine-solid lipid nanoparticles as a non-viral vector for
gene therapy: In vitro characterization and in vivo transfection after intravenous administra-
tion to mice. Int J Pharm 425:35-43
Deng X, Cao M, Zhang J, Hu K, Yin Z, Zhou Z, Xiao X, Yang Y, Sheng W, Wu Y, Zeng Y (2014)
Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in
therapy against triple negative breast cancer. Biomaterials 35(14):4333-4444
Denkewalter RG, Kolc J, Lukasavage WJ (1981) Macromolecular highly branched homogenous
compound based on lysine units. US Patent 4, 289-872
Dennis MS, Jin H, Dugger D, Yang R, McFarland L, Ogasawara A, Williams S, Cole MJ, Ross
S, Schwall R (2007) Imaging tumors with an albumin-binding fab, a novel tumor-targeting
agent. Cancer Res 67:254-261
Destito G, Yeh R, Rae CS, Finn MG, Manchester M (2007) Folic acid-mediated targeting of
cowpea mosaic virus particles to tumor cells. Chem Biol 14:1152-1162
Ding D, Wang J, Zhu Z, Li R, Wu W, Liu B, Jiang X (2012) Tumor accumulation, penetration,
and antitumor response of cisplatin-loaded gelatin/poly(acrylic acid) nanoparticles. ACS Appl
Mater Interfaces 4:1838-1846
Doktorovova S, Shegokar R, Rakovsky E, Mira EG, Lopesa CM, Silva AM, Lopesa PM, Mullerb
RH, Soutoa EB (2011) Cationic solid lipid nanoparticles (cSLN): structure, stability and
DNA binding capacity correlation studies. Int J Pharm 420:341-349
Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer
3:380-387
Dong Y, Ng WK, Shen S, Kim S, Tan RB (2012) Solid lipid nanoparticles: continuous and poten-
tial large-scale nanoprecipitation production in static mixers. Colloids Surf B 94:68-72
Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998)
Photodynamic therapy. J Natl Cancer Inst 90:889-905
Drain CM, Varotto A, Radivojevic I (2009) Self-organized porphyrinic materials. Chem Rev
109:1630-1658
Duncan R (1992) Drug-polymer conjugates: potential for improved chemotherapy. Anticancer
Drugs 3:175-210
Duncan R (2003) The dawning era of polymer therapeutics. Nat Rev Drug Discov 2:347-360
Egusquiaguirre SP, Igartua M, Hernández RM, Pedraz JL (2012) Nanoparticle delivery systems
for cancer therapy: advances in clinical and preclinical research. Clin Transl Oncol 14:83-93
Eldeen A, Yassin B, Anwer MK, Mowafy HA, Bagory IME, Bayomi MA, Alsarra IA (2010)
Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon
cancer. Int J Med Sci 7:398-408
Eldeen A, Yassin B, Albekairy A, Alkatheri A, Sharma RK (2013) Anticancer-loaded solid lipid
nanoparticles: high potential, advancement in chemotherapy. Dig J Nanomater Biostruct
8:905-916
